Impel Pharmaceuticals Inc

IMPLCIK 0001445499 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Mar 31, 2023. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0066

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Mar 12, 2024no items parsed Feb 14, 2024no items parsed Jan 2, 2024no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Impel Pharmaceuticals Inc

Name	Roles	Filings
Allison David D.	Director	3
Leaman John Harold	Officer	3
Nelson Timothy S	Director	3
Wilfong Diane E.	Director	3
Adams Adrian	OfficerDirector	2

Showing 1-5 of 37

Per pagePage 1 of 8Next

All filings

30 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Feb 16, 2023	Leaman John Harold Chief Fin. & Business Officer	Holdings only	-	-	-
Feb 16, 2023	Hoekman John Chief Scientific Officer	Holdings only	-	-	-
Feb 16, 2023	Paolillo Leonard Chief Commercial Officer	Holdings only	-	-	-
Jan 4, 2023	Leaman John Harold Chief Fin. & Business Officer	FTax	3,627	$3.75	$13,601
Jun 17, 2022	Allison David D. Director	Holdings only	-	-	-

Showing 16-20 of 30

Per pagePrevPage 4 of 6Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value